Matt Bivens / TruthdigFeb 4, 2026
Though publicly shamed, the Sacklers avoided prison, remained billionaires, and are set to launch a new company, Knoa Pharma. Dig deeper ( 8 Min. Read )
Matt Bivens / TruthdigJan 9, 2026
The former opioid empire’s bankruptcy deal is delivering up 43 million documents that shed light on the company’s cold-blooded strategy to addict as many Americans as possible. Dig deeper ( 10 Min. Read )
Matt Bivens / TruthdigNov 27, 2024
Some members of the notorious Sackler family have returned to blaming doctors for the opioid crisis. Are they even wrong? Dig deeper ( 6 Min. Read )
Join our newsletterStay up to date with the latest from Truthdig. Join the Truthdig Newsletter for our latest publications.
Matt Bivens / TruthdigSep 7, 2024
The opioid epidemic would not have been possible without the cooperation of the House of Medicine, from journals to the AMA. Dig deeper ( 15 Min. Read )
Matt Bivens / TruthdigJun 20, 2024
With five sentences, two researchers gamed the medical journals and confused a generation of doctors about the addiction potential of opioids. Dig deeper ( 11 Min. Read )
GEOFF MULVIHILL / The Associated PressJan 24, 2020
A federal judge overseeing the drug company's bankruptcy case sets a June 30 claims deadline and allows CEO to collect a $1.3 million bonus. Dig deeper ( 3 Min. Read )
Mattea Kramer / TomDispatchNov 20, 2019
The pharmaceutical executives behind the opioid crisis could learn a thing or two from people in recovery from drug addiction. Dig deeper ( 8 Min. Read )
CARLA K. JOHNSON and GEOFF MULVIHILL / The Associated PressOct 6, 2019
Four people touched by addiction are on a bankruptcy committee that will help decide Purdue's fine and potentially, how that money will be spent. Dig deeper ( 5 Min. Read )
GEOFF MULVIHILL and DAVE COLLINS / The Associated PressSep 11, 2019
Several state attorneys general vow to continue their legal battles against the Sackler family and Purdue Pharma in bankruptcy court. Dig deeper ( 4 Min. Read )
David Armstrong and Jeff Ernsthausen / ProPublicaSep 10, 2019
Purdue Pharma maintains it was a minor player in the U.S. market for OxyContin. A new analysis of government data suggests otherwise. Dig deeper ( 8 Min. Read )
Chris Hedges and Mr. Fish / TruthdigSep 9, 2019
A Business Roundtable statement about the purpose of corporations shows that ruling elites fear their crimes are coming back to haunt them. Dig deeper ( 6 Min. Read )
David Armstrong / ProPublicaAug 27, 2019
In 2015, Purdue Pharma's former chairman and president admits he illegally marketed OxyContin by understating its addictive properties. Dig deeper ( 3 Min. Read )
Join our newsletterDon't miss out on the latest investigations, art critiques, provocative insights and original reporting from a progressive perspective — delivered straight to your inbox.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, please login or create a user profile.
Now you can personalize your Truthdig experience. To bookmark your favorite articles and follow your favorite authors, upgrade to supporter.